Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4749942
Max Phase: Preclinical
Molecular Formula: C50H53F3N3O11P
Molecular Weight: 846.94
Molecule Type: Unknown
Associated Items:
ID: ALA4749942
Max Phase: Preclinical
Molecular Formula: C50H53F3N3O11P
Molecular Weight: 846.94
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H]1c2ccc(NC(=O)CCCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)c(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O=C([O-])C(F)(F)F
Standard InChI: InChI=1S/C48H52N3O9P.C2HF3O2/c1-28-32-25-26-33(41(53)36(32)42(54)37-35(28)43(55)39-40(51(2)3)44(56)38(47(49)59)46(58)48(39,60)45(37)57)50-34(52)24-16-5-4-6-17-27-61(29-18-10-7-11-19-29,30-20-12-8-13-21-30)31-22-14-9-15-23-31;3-2(4,5)1(6)7/h7-15,18-23,25-26,28,35,39-40,43,55,60H,4-6,16-17,24,27H2,1-3H3,(H5-,49,50,52,53,54,56,57,58,59);(H,6,7)/t28-,35+,39+,40-,43-,48-;/m0./s1
Standard InChI Key: PYHHPMRMLHUOME-YCPVPSFISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 846.94 | Molecular Weight (Monoisotopic): 846.3514 | AlogP: 4.93 | #Rotatable Bonds: 14 |
Polar Surface Area: 210.72 | Molecular Species: ACID | HBA: 10 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.87 | CX Basic pKa: 7.78 | CX LogP: 2.57 | CX LogD: 2.08 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.04 | Np Likeness Score: 0.84 |
1. Cochrane EJ,Hulit J,Lagasse FP,Lechertier T,Stevenson B,Tudor C,Trebicka D,Sparey T,Ratcliffe AJ. (2021) Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells., 12 (4.0): [PMID:33859798] [10.1021/acsmedchemlett.0c00632] |
Source(1):